Concepedia

Jan Stach

JS

Statistics

Publications

7

Citations

117

H-Index

7

Active since

1967

Affiliations

Sanofi (Czechia)(Current)

University of Chemistry and Technology, Prague

Jan Stach is an author at Sanofi (Czechia) specializing in pharmacology, medicine, and medicinal chemistry.

Top concepts

PharmacologyMedicineNatural SciencesOrganic ChemistryMedicinal ChemistryChemistryBiochemistryDrug DiscoveryBioorganic ChemistryEngineering

Publications per year

1967–2015

7

Publications

7

An improved synthesis of 1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate, a key intermediate for atorvastatin synthesis

S. Rádl, Jan Stach, Josef Hájíček · Tetrahedron Letters · 2002 · 26 citations

Diversity Oriented Synthesis, Key Intermediate, Engineering +7

Improved Process for Azilsartan Medoxomil: A New Angiotensin Receptor Blocker

S. Rádl, Josef Černý, Jan Stach et al. · Organic Process Research & Development · 2012 · 25 citations

Hypertension, Azilsartan Medoxomil, Active Pharmaceutical Ingredient +19

A sealed gate IGFET

H. E. Nigh, Jan Stach, Ryan Jacobs · IEEE Transactions on Electron Devices · 1967 · 16 citations

Hardware Security, Electrical Engineering, Engineering +3

An Improved Synthesis of Elvitegravir

S. Rádl, Jan Stach, Ondřej Píša et al. · Journal of Heterocyclic Chemistry · 2015 · 15 citations

Active Pharmaceutical Ingredient, Bioorganic Chemistry, Organic Chemistry +17

Synthesis of Some Impurities and/or Degradation Products of Atorvastatin

Jan Stach, Jaroslav Havlı́ček, Lukáš Plaček et al. · Collection of Czechoslovak Chemical Communications · 2008 · 12 citations

Pharmaceutical Science, Bioorganic Chemistry, C Nmr +18

1–5 of 7